Livzon Pharmaceutical Group's total assets for Q1 2025 were ¥24.49B, an increase of 0.12% from the previous quarter. LVZPF total liabilities were ¥9.11B for the fiscal quarter, a -4.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.